VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+3.91%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$245M
AUM Growth
+$31M
(+15%)
Cap. Flow
+$30.8M
Cap. Flow
% of AUM
12.58%
Top 10 Holdings %
Top 10 Hldgs %
7.31%
Holding
511
New
57
Increased
251
Reduced
151
Closed
49
Top Buys
| 1 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
$1.88M |
| 2 |
DocuSign
DOCU
|
$1.49M |
| 3 |
United Airlines
UAL
|
$1.47M |
| 4 |
Fortinet
FTNT
|
$1.35M |
| 5 |
Spotify
SPOT
|
$1.34M |
Top Sells
| 1 |
Applovin
APP
|
$1.45M |
| 2 |
Expedia Group
EXPE
|
$1.04M |
| 3 |
KKR & Co
KKR
|
$976K |
| 4 |
CME Group
CME
|
$974K |
| 5 |
Corpay
CPAY
|
$948K |
Sector Composition
| 1 | Financials | 29.48% |
| 2 | Technology | 14.86% |
| 3 | Healthcare | 14.81% |
| 4 | Industrials | 11.61% |
| 5 | Consumer Discretionary | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Altimmune
ALT
$334M
| $59.7K | 0.02% |
+8,277
| New | +$59.7K |
|
452
Immunome
IMNM
$916M
| $57.8K | 0.02% |
5,440
-303
| -5% | -$3.22K |
|
453
4D Molecular Therapeutics
FDMT
$340M
| $57.6K | 0.02% |
10,333
+6,560
| +174% | +$36.5K |
|
454
Sana Biotechnology
SANA
$752M
| $56.8K | 0.02% |
34,849
+21,959
| +170% | +$35.8K |
|
455
Taysha Gene Therapies
TSHA
$917M
| $54.7K | 0.02% |
31,597
+9,494
| +43% | +$16.4K |
|
|
IGMS
456
DELISTED
IGM Biosciences
IGMS
| $52.8K | 0.02% |
8,649
-2,957
| -25% | -$18.1K |
|
|
BCYC
457
Bicycle Therapeutics
BCYC
$496M
| $49.5K | 0.02% |
3,535
-254
| -7% | -$3.56K |
|
458
Corvus Pharmaceuticals
CRVS
$459M
| $47.1K | 0.02% |
+8,799
| New | +$47.1K |
|
459
SITE Centers
SITC
$490M
| $45.9K | 0.02% |
3,003
-11,471
| -79% | -$175K |
|
460
Larimar Therapeutics
LRMR
$337M
| $45K | 0.02% |
11,635
+2,127
| +22% | +$8.23K |
|
461
Scilex Holding
SCLX
$159M
| $7.27K | ﹤0.01% |
513
| – | – |
|
462
Apple
AAPL
$3.56T
| – | – |
-4,062
| Closed | -$946K |
|
|
AGEN
463
Agenus
AGEN
$138M
| – | – |
-5,759
| Closed | -$31.6K |
|
464
Arthur J. Gallagher & Co
AJG
$76.7B
| – | – |
-3,122
| Closed | -$878K |
|
465
Alector
ALEC
$305M
| – | – |
-18,697
| Closed | -$87.1K |
|
466
ALX Oncology
ALXO
$65.3M
| – | – |
-10,920
| Closed | -$19.9K |
|
467
Ametek
AME
$43.3B
| – | – |
-5,140
| Closed | -$883K |
|
468
Applied Therapeutics
APLT
$68.2M
| – | – |
-17,524
| Closed | -$149K |
|
|
JBIO
469
Jade Biosciences, Inc. Common Stock
JBIO
$254M
| – | – |
-107
| Closed | -$7.84K |
|
470
Cabaletta Bio
CABA
$155M
| – | – |
-7,338
| Closed | -$34.6K |
|
471
Cadence Design Systems
CDNS
$95.6B
| – | – |
-3,421
| Closed | -$927K |
|
|
472
CME Group
CME
$94.4B
| – | – |
-4,415
| Closed | -$974K |
|
473
Cencora
COR
$56.7B
| – | – |
-3,890
| Closed | -$876K |
|
474
Copart
CPRT
$47B
| – | – |
-17,344
| Closed | -$909K |
|
475
Cognizant
CTSH
$35.1B
| – | – |
-11,873
| Closed | -$916K |
|